One year follow-up of patients with refractory angina pectoris treated with enhanced external counterpulsation

Login or register to view PDF.


Enhanced external counterpulsation (EECP) is a non-invasive technique that has been shown to be effective in reducing both angina and myocardial ischemia in patients not responding to medical therapy and without revascularization alternatives. The aim of the present study was to assess the long-term outcome of EECP treatment at a Scandinavian centre, in relieving angina in patients with chronic refractory angina pectoris.

55 patients were treated with EECP. Canadian cardiovascular society (CCS) class, antianginal medication and adverse clinical events were collected prior to EECP, at the end of the treatment, and at six and 12 months after EECP treatment. Clinical signs and symptoms were recorded.

EECP treatment significantly improved the CCS class in 79 ± 6% of the patients with chronic angina pectoris (p < 0.001). The reduction in CCS angina class was seen in patients with CCS class III and IV and persisted 12 months after EECP treatment. There was no significant relief in angina in patients with CCS class II prior to EECP treatment. 73 ± 7% of the patients with a reduction in CCS class after EECP treatment improved one CCS class, and 22 ± 7% of the patients improved two CCS classes. The improvement of two CCS classes could progress over a six months period and tended to be more prominent in patients with CCS class IV. In accordance with the reduction in CCS classes there was a significant decrease in the weekly nitroglycerin usage (p < 0.05).

The results from the present study show that EECP is a safe treatment for highly symptomatic patients with refractory angina. The beneficial effects were sustained during a 12-months follow-up period./>/>/>/>/>/>



  1. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliasson T, Follath F, Hellemans I, Herlitz J, Luscher T, Pasic M, Thelle D: The problem of chronic refractory angina; report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002, 23:355-370.
  2. Yang EH, Barsness GW, Gersh BJ, Chandrasekaran K, Lerman A: Current and future treatment strategies for refractory angina. Mayo Clin Proc 2004, 79:1284-1292.
  3. Mannheimer C: Therapeutic challenges of refractory angina pectoris. In: XXth Congress of the European Society of. Cardiology, Vienna, Austria 1998.
  4. de Jongste MJ, Hautvast RW, Hillege HL, Lie KI: Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris: a prospective, randomized clinical study. Working Group on Neurocardiology. J Am Coll Cardiol 1994, 23:1592-1597.
  5. Ekre O, Norrsell H, Wahrborg P, Eliasson T, Mannheimer C: Temporary cessation of spinal cord stimulation in angina pectoris-effects on symptoms and evaluation of long-term effect determinants. Coron Artery Dis 2003, 14:323-327.
  6. Chester M, Hammond C, Leach A: Long-term benefits of stellate ganglion block in severe chronic refractory angina. Pain 2000, 87:103-105.
  7. Richter A, Cederholm I, Jonasson L, Mucchiano C, Uchto M, Janerot-Sjoberg B: Effect of thoracic epidural analgesia on refractory angina pectoris: long-term home self-treatment. J Cardiothorac Vasc Anesth 2002, 16:679-684.
  8. Lawson WE, Hui JC, Soroff HS, Zheng ZS, Kayden DS, Sasvary D, Atkins H, Cohn PF: Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. Am J Cardiol 1992, 70:859-862.
  9. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto RW: The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 1999, 33:1833-1840.
  10. Taguchi I, Ogawa K, Kanaya T, Matsuda R, Kuga H, Nakatsugawa M: Effects of enhanced external counterpulsation on hemodynamics and its mechanism. Circ J 2004, 68:1030-1034.
  11. Michaels AD, Accad M, Ports TA, Grossman W: Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. Circulation 2002, 106:1237-1242.
  12. Bonetti PO, Holmes DRJ, Lerman A, Barsness GW: Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain? J Am Coll Cardiol 2003, 41:1918-1925.
  13. Michaels AD, Linnemeier G, Soran O, Kelsey SF, Kennard ED: Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). Am J Cardiol 2004, 93:461-464.
  14. Springer S, Fife A, Lawson W, Hui JC, Jandorf L, Cohn PF, Fricchione G: Psychosocial effects of enhanced external counterpulsation in the angina patient: a second study. Psychosomatics 2001, 42:124-132.
  15. Lawson WE, Hui JC, Lang G: Treatment benefit in the enhanced external counterpulsation consortium. Cardiology 2000, 94:31-35.
  16. Stys T, Lawson WE, Hui JC, Lang G, Liuzzo J, Cohn PF: Acute hemodynamic effects and angina improvement with enhanced external counterpulsation. Angiology 2001, 52:653-658.
  17. Barsness G, Feldman AM, Holmes DRJ, Holubkov R, Kelsey SF, Kennard ED: The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol 2001, 24:435-442.
  18. Barsness GW: Enhanced external counterpulsation in unrevascularizable patients. Curr Interv Cardiol Rep 2001, 3:37-43.
  19. Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, Walter K: Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol 1993, 21:359-368.
  20. Kuchan MJ, Frangos JA: Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am J Physiol 1993, 264:H150-6.
  21. Davies PF: Flow-mediated endothelial mechanotransduction. Physiol Rev 1995, 75:519-560.
  22. Masuda D, Nohara R, Hirai T, Kataoka K, Chen LG, Hosokawa R, Inubushi M, Tadamura E, Fujita M, Sasayama S: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. Eur Heart J 2001, 22:1451-1458.
  23. Kersten JR, Pagel PS, Chilian WM, Warltier DC: Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia. Cardiovasc Res 1999, 43:44-57.
  24. D Masuda RNTHKKLGCRHMIETMFSS: Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina. Evaluation by13N-ammonia positron emission tomography. Eur Heart J 2001, 22:1451-1458.
  25. Lawson WE, Kennard ED, Hui JC, Holubkov R, Kelsey SF: Analysis of baseline factors associated with reduction in chest pain in patients with angina pectoris treated by enhanced external counterpulsation. Am J Cardiol 2003, 92:439-443.
  26. Lawson WE, Hui JC, Kennard ED, Barsness G, Kelsey SF: Predictors of benefit in angina patients one year after completing enhanced external counterpulsation: initial responders to treatment versus nonresponders. Cardiology 2005, 103:201-206.
  27. Niebauer J, Cooke JP: Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996, 28:1652-1660.
  28. Bonetti PO, Barsness GW, Keelan PC, Schnell TI, Pumper GM, Kuvin JT, Schnall RP, Holmes DR, Higano ST, Lerman A: Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. J Am Coll Cardiol 2003, 41:1761-1768.
  29. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, Nesto R, Ferrans CE, Keller S: Effects of enhanced external counterpulsation on Health-Related Quality of Life continue 12 months after treatment: a substudy of the Multicenter Study of Enhanced External Counterpulsation. J Investig Med 2002, 50:25-32.